As was noted in this space some time ago, the Pennsylvania Supreme Court was considering an employer’s petition for allowance ...

New Hampshire and Arkansas were found to have the highest rates of unnecessary spinal fusions and/or laminectomies and vertebroplasties, respectively, according ...

By contrast, ChatGPT 4.0 hit 100% accuracy for diagnostic testing and a 33% accuracy rate for surgical intervention ...

Spinal fusion and laminectomy procedures were deemed overused for patients with low back pain, excluding those with radicular symptoms, trauma, herniated disc, discitis, spondylosis, myelopathy, ...

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

Biotech companies have brought many important treatments to market, from ones that address rare diseases to ones that handle ...

It is said that the survey department conducted a survey on the lake land on August 4, 2021, and found that three acres and ...

Four-level cervical disc replacement is rare, but a small study published in the October issue of the International Journal of Spine Surgery found the procedure ...

A chart-review study found low-dose dexamethasone mixed with local anesthetic was the optimal injectate for use in ILESIs for lumbar radiculopathy.

Vertex Pharmaceuticals beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.Please watch the video at Investors.com - How To Buy ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $476 from $473 and keeps an Equal ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The ...